malondialdehyde has been researched along with Myeloproliferative Disorders in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barbui, T; Bassan, R; Cortelazzo, S; Viero, P | 1 |
Cunietti, E; Ferrari, M; Gandini, R; Mascaro, G; Pappalepore, V; Scapellato, L | 1 |
Dean, S; Phadke, K; Pitney, WR | 1 |
Ibayashi, H; Motomura, S; Nishimura, J; Okamoto, S | 1 |
Bellingham, AJ; Keenan, JP; Shepherd, AJ; Wharton, J | 1 |
Boda, Z; Kiss, A; Nagy, P; Pecze, K; Pfliegler, G; Rak, K; Telek, B; Udvardy, M | 1 |
Flener, R; Gisslinger, H; Linkesch, W; Ludwig, H; Peskar, BA; Sinzinger, H | 1 |
7 other study(ies) available for malondialdehyde and Myeloproliferative Disorders
Article | Year |
---|---|
Effect of aspirin on platelet 5-hydroxytryptamine and beta-thromboglobulin plasma levels in patients with myeloproliferative diseases.
Topics: Adult; Aged; Aspirin; Beta-Globulins; beta-Thromboglobulin; Blood Platelets; Female; Humans; Leukemia, Myeloid; Male; Malondialdehyde; Middle Aged; Myeloproliferative Disorders; Primary Myelofibrosis; Serotonin | 1982 |
Defective platelet aggregation and increased platelet turnover in patients with myelofibrosis and other myeloproliferative diseases.
Topics: Adult; Aged; beta-Thromboglobulin; Blood Platelets; Female; Humans; Male; Malondialdehyde; Middle Aged; Myeloproliferative Disorders; Platelet Aggregation; Primary Myelofibrosis | 1981 |
Platelet dysfunction in myeloproliferative syndromes.
Topics: Aspirin; Blood Platelets; Humans; Malondialdehyde; Mathematics; Myeloproliferative Disorders; Platelet Aggregation; Prostaglandins | 1981 |
Platelet dysfunctions in myeloproliferative disorders: the different mechanisms of abnormal responses to collagen and arachidonic acid.
Topics: Adenine Nucleotides; Adolescent; Adult; Aged; Arachidonic Acids; Collagen; Female; Humans; Male; Malondialdehyde; Middle Aged; Myeloproliferative Disorders; Platelet Aggregation | 1981 |
Defective platelet lipid peroxidation in myeloproliferative disorders: a possible defect of prostaglandin synthesis.
Topics: Blood Platelet Disorders; Contusions; Ethylmaleimide; Humans; Lipid Metabolism; Malondialdehyde; Myeloproliferative Disorders; Peroxides; Prostaglandins | 1977 |
Platelet function studies in myeloproliferative disorders.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Aged, 80 and over; beta-Thromboglobulin; Blood Platelets; Female; Humans; Male; Malondialdehyde; Middle Aged; Myeloproliferative Disorders; Platelet Aggregation; Platelet Count; Platelet Function Tests; Thromboxane B2 | 1986 |
[Defects in the prostaglandin system. VIII. A pathologic thrombocyte population in myeloproliferative syndrome, which forms no thromboxane from exogenous arachidonic acid].
Topics: Aged; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Humans; Male; Malondialdehyde; Myeloproliferative Disorders; Platelet Function Tests; Polycythemia Vera; Thrombocytosis; Thromboxane B2 | 1988 |